Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

被引:237
作者
Mukadi, YD
Maher, D
Harries, A
机构
[1] Family Hlth Int, HIV AIDS Prevent & Care Dept, Arlington, VA 22201 USA
[2] WHO, Communicable Dis Control Prevent & Eradicat Dept, CH-1211 Geneva, Switzerland
[3] Natl TB Control Programme, Lilongwe, Malawi
关键词
tuberculosis; HIV; mortality; sub-Saharan Africa;
D O I
10.1097/00002030-200101260-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Tuberculosis is a leading cause worldwide of morbidity and mortality among HIV-infected people. The HIV era has seen a dramatic increase of the tuberculosis case fatality rate (CFR) in high HIV prevalence populations. Providing care for HIV-infected people must include measures to tackle this high tuberculosis CFR. Aims: To analyse the extent of the increased tuberculosis CFR in high HIV prevalence populations in sub-Saharan Africa, the reasons for this increase and the causes of death, in order to identify possible ways of tackling this problem. Methods: References were obtained by searching the MEDLINE on 'tuberculosis', 'HIV infection', and 'mortality' (MesH or textword). In addition, available data from National Tuberculosis Programme reports were reviewed. Findings: Tuberculosis CFR is closely linked to HIV prevalence. Limited autopsy data suggest that death from HIV-related diseases other than tuberculosis is probably the main reason for the increased CFR in HIV-infected tuberculosis patients. Among HIV-infected tuberculosis patients, the higher tuberculosis CFR in sputum smear-negative and extrapulmonary than in sputum smear-positive tuberculosis cases can also be attributed to misdiagnosis of HIV-related diseases as tuberculosis. The adverse effect of the HIV/AIDS epidemic on general health service performance probably accounts for the higher tuberculosis CFR among HIV-negative tuberculosis patients in high prevalence populations than that in low HIV-prevalence populations. Conclusion: Tackling the problem of the increased tuberculosis CFR in high HIV prevalence populations requires collaboration between tuberculosis control and HIV/ AIDS programmes in implementing measures such as improved health services, tuberculosis and HIV control services, preventive treatment for HIV-related diseases and anti-HIV treatment. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 56 条
  • [31] Malkin JE, 1997, INT J TUBERC LUNG D, V1, P68
  • [32] MEHER D, 1997, WHOTB97220
  • [33] Changing patterns of mortality across Europe in patients infected with HIV-1
    Mocroft, A
    Vella, S
    Benfield, TL
    Chiesi, A
    Miller, V
    Gargalianos, P
    Monforte, AD
    Yust, I
    Bruun, JN
    Phillips, AN
    Lundgren, JD
    [J]. LANCET, 1998, 352 (9142) : 1725 - 1730
  • [34] Moorman J, 1999, INT J TUBERC LUNG D, V3, P786
  • [35] Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients
    Murray, J
    Sonnenberg, P
    Shearer, SC
    Godfrey-Faussett, P
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : 733 - 740
  • [36] Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung
    Nakata, K
    Rom, WN
    Honda, Y
    Condos, R
    Kanegasaki, S
    Cao, YZ
    Weiden, M
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (03) : 996 - 1003
  • [37] COHORT STUDY OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN PATIENTS WITH TUBERCULOSIS IN NAIROBI, KENYA - ANALYSIS OF EARLY (6-MONTH) MORTALITY
    NUNN, P
    BRINDLE, R
    CARPENTER, L
    ODHIAMBO, J
    WASUNNA, K
    NEWNHAM, R
    GITHUI, W
    GATHUA, S
    OMWEGA, M
    MCADAM, K
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (04): : 849 - 854
  • [38] Onyebujoh PC, 1999, LANCET, V354, P116, DOI 10.1016/S0140-6736(98)10448-8
  • [39] Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
    Palella, FJ
    Delaney, KM
    Moorman, AC
    Loveless, MO
    Fuhrer, J
    Satten, GA
    Aschman, DJ
    Holmberg, SD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) : 853 - 860
  • [40] MALABSORPTION OF ANTIMYCOBACTERIAL MEDICATIONS
    PELOQUIN, CA
    MACPHEE, AA
    BERNING, SE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (15) : 1122 - 1123